, and a new isocoumarine, 6-hydroxy-5,8-dimethoxy-3-methyl-1H-isochromen-1-one (4), along with two known compounds (+)-4,8-dihydroxy-7-(2-hydroxy-ethyl)-6-methoxy-3,4-dihydro-2H-naphthalen-1-one ((+)-2) and (+)-10-norparvulenone (3) were isolated from the marine-derived fungus Leptosphaerulina chartarum 3608. The structures of new compounds were elucidated by HR-ESIMS, NMR, and ECD analysis. All compounds were evaluated for cytotoxicity and anti-inflammatory activity. Compound 6 showed moderate anti-inflammatory activity by inhibiting the production of nitric oxide (NO) in lipopolysaccharide-stimulated RAW264.7 cells, with an IC 50 value of 44.5 µM.
Introduction
Marine-derived micro-organisms are known as a rich source of natural products with novel structure and interesting bioactivities [1] . A large number of the new compounds from marine-derived fungi are discovered every year. Among these, naphthalenone derivatives are side products of the 1,8-dihydroxynaphthalene polyketide pathway [2] , which are common in the secondary metabolites from fungi with diverse bioactivities, such as antimicrobial [3] , antiviral [4] , cytotoxic [5] , and antimalarial activities [3] . Besides, naphthalenone derivatives have structural diversity not only in the planar structure but also in the absolute configuration. Abdel-Latef et al. reported a pair epimer of (3R*,4S*)-3,4-dihydroxy-7-methyl-3,4-dihydro-1(2H)-naphthalenone and (3S*,4S*) -3,4-dihydroxy-7-methyl-3,4-dihydro-1(2H) -naphthalenone from the Algicolous marine fungus Acremonium sp. [6] . Wang et al. isolated a pair of naphthalenone enantiomers, corynenones A and B, from sponge-derived fungus Corynespora cassiicola [7] .
During our ongoing research on secondary metabolites from marine-derived fungus, five new naphthalenones, two enantiomers (−)-1 and (+)-1 leptothalenone A, (−) -4,8-dihydroxy-7 -(2-hydroxyethyl)-6-methoxy-3,4-dihydro-2H-naphthalen-1-one ((−)-2), (4S, 10R, 4 S)-leptothalenone B (5), (4R, 10S, 4 S)-leptothalenone B (6) , and a new isocoumarine (4) , along with two known compounds (+) -4,8-dihydroxy-7 -(2-hydroxy-ethyl)-6-methoxy-3,4-dihydro-2H-naphthalen-1-one ((+)-2) and (+)-10-norparvulenone (3) ( Figure 1 ) were isolated from Leptosphaerulina chartarum 3608 from a crinoid collected in Xuwen, Zhanjiang City, Guangdong Province, China. In this paper, we described the structure determination of the new compounds as well as the bioactivity assay of these isolated compounds from the CHCl 3 extract of L. chartarum 3608.
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Results and Discussion
Compound (±)-1 was obtained as a light brown powder and had a molecular formula C13H16O5 according to the positive HR-ESIMS ion at m/z 275.0885 [M + Na] + (calculated for C13H16O5Na, 275.0890), indicating six degrees of unsaturation. The 1 H NMR data (Table 1) revealed the presence of one five-substituted aromatic proton [δH 6.79 (1H, s, H-5) ], one methoxyl [δH 3.92 (3H, s, H-9) ], one methyl [δH 1.48 (3H, d, J = 6.8, H-11) ], two methenes [δH 2.62 (1H, m, H-2) , δH 2.79 (1H, m, H-2), δH 2.01 (1H, m, H-3), δH 2.26 (1H, m, H-2)], two oxygenated methines [δH 4.77 (1H, dd, J = 8.9, 3.9, H-4), δH 5.31 (1H, s, H-11) ]. The 13 C NMR and DEPT spectra displayed a ketone carbonyl (δC 204.6), six aromatic carbons (δC 164.8, 162.7, 150.2, 119.1, 111.1, 102.2) , an oxygenated methyl (δC 56.4), two oxygenated methine (δC 68.6 and 63.4), and two methylenes (δC 36. 1 and 32.7) . Further analyses of the NMR data showed that compound 1 shared a good similarity with the known compound O-methylasparvenone [8] , except for an extra hydroxyl group which was connected to C-10 based on the chemical shift values (δH/C 5.31 and 63.4, H-10 and C-10) and the 1 H-1 H COSY correlation of H-10 and H-11, as well as the HMBC correlation of H-11 with C-10 and C-7. Thus, the planar structure of 1 was successfully assigned as 9-hydroxyl-O-methylasparvenone ( Figure 1 ).
Compound 1 was of racemic nature because it lacked any CD (circular dichroism) maximum and optical rotation. Subsequent chiral HPLC purification of (±)-1 led to the separation of the two enantiomers, (−)-1 and (+)-1 (Figure 2a 
Compound (±)-1 was obtained as a light brown powder and had a molecular formula C 13 4.77 (1H, dd, J = 8.9, 3.9, H-4) , δ H 5.31 (1H, s, H-11)]. The 13 C NMR and DEPT spectra displayed a ketone carbonyl (δ C 204.6), six aromatic carbons (δ C 164. 8, 162.7, 150.2, 119.1, 111.1, 102.2) , an oxygenated methyl (δ C 56.4), two oxygenated methine (δ C 68.6 and 63.4), and two methylenes (δ C 36. 1 and 32.7) . Further analyses of the NMR data showed that compound 1 shared a good similarity with the known compound O-methylasparvenone [8] , except for an extra hydroxyl group which was connected to C-10 based on the chemical shift values (δ H/C 5.31 and 63.4, H-10 and C-10) and the 1 H-1 H COSY correlation of H-10 and H-11, as well as the HMBC correlation of H-11 with C-10 and C-7. Thus, the planar structure of 1 was successfully assigned as 9-hydroxyl-O-methylasparvenone ( Figure 1 ).
Compound 1 was of racemic nature because it lacked any CD (circular dichroism) maximum and optical rotation. Subsequent chiral HPLC purification of (±)-1 led to the separation of the two enantiomers, (−)-1 and (+)-1 (Figure 2a Figure 2b . The predicted ECD curve of (4R,10R)-1 was in accordance with the experimental ECD curve of (−)-1, and (4S,10S)-1 was also in agreement with the experimental ECD curve of (+)-1 ( Figure 2b ). This result suggested that the absolute configuration of (−)-1 was 4R, 10R and (+)-1 was 4S, 10S. Therefore, (±)-1 was named as (±)-leptothalenone A. negative CEs at 238, 282 nm. To determine the absolute configuration of (−)-1 and (+)-1, their theoretical ECD spectra of four possible configurations
were calculated by a quantum chemical method at the [B3LYP/6-311+G(2d,p)] level and are shown in Figure 2b . The predicted ECD curve of (4R,10R)-1 was in accordance with the experimental ECD curve of (−)-1, and (4S,10S)-1 was also in agreement with the experimental ECD curve of (+)-1 ( Figure 2b ). This result suggested that the absolute configuration of (−)-1 was 4R, 10R and (+)-1 was 4S, 10S. Therefore, (±)-1 was named as (±)-leptothalenone A. Compound (±)-2 was obtained as a light yellow powder. Its molecular formula was determined as C13H16O5 according to the positive HR-ESIMS ([M + Na] + m/z 275.0885, calculated for C13H16O5Na) and was the same as (±)-leptothalenone A. Through analysis of the NMR data of (±)-2 (Tables 1 and 2 , Figure 3 ), the planar structure of (±)-2 was identified as the known compound 4,8-dihydroxy-7-(2-hydroxy-ethyl)-6-methoxy-3,4-dihydro-2H-naphthalen-1-one with positive Compound (±)-2 was obtained as a light yellow powder. Its molecular formula was determined as C 13 [9] , whose configuration has never been determined. Using the Figure 4) . Thus, the configuration of known compound (+)-2 was assigned as 4R, while the enantiomer (−)-2 was a new compound with the configuration of 4S. O 5 with seven degrees of unsaturation. The 1D and 2D NMR data indicated that compound 4 shared the same isocoumarin skeleton as 6,8-dihydroxy-5-methoxy-3-methyl-1H-isochromen-1-one [10] . The only difference between them was that the hydroxyl group (8-OH) of the known compound was replaced by a methoxyl group (8-OCH 3 ) of 4, which was further confirmed by the HMBC correlation of H-10 to C-5 and C-6. Hence, compound 4 was assigned as 6-hydroxy-5,8-dimethoxy-3-methyl-1H-isochromen-1-one.
Compounds 5 and 6 were both isolated as a light brown amorphous powder from the same fraction using the RP-HPLC [MeOH-H 2 O 60:40, t R (5) = 52 min, t R (6) = 56 min], implying they were epimers. ] indicated that 6 was a stereoisomer of 5. They had the same molecular formula C 25 H 28 O 9 , which was determined by HR-ESIMS at m/z 495.1628 (calculated for C 25 H 28 O 9 Na, 495.1626), corresponding to 12 degrees of unsaturation. The IR spectrum displayed absorption at 3383 cm −1 indicative of the existence of hydroxyl group. The 1 H and 13 C NMR spectra of compounds 5 and 6 revealed the presence of 24 protons and 25 carbons (two ketone carbonyls, ten aromatic quaternary carbons, two aromatic methines, three methyls, five methylenes, three methine). There were 14 sp 2 carbon signals (two of which were carbonyls) that appeared pairwise in 13 C NMR spectrum indicating that 5 and 6 were heterodimers of naphthalenones. Detailed analysis of the 1 H-1 H COSY and HMBC spectra (Figure 3) , compounds 5 and 6 had the same planar structures as two monomeric units leptothalenone A (1) and 10-norparvulenone carbon signals (two of which were carbonyls) that appeared pairwise in 13 C NMR spectrum indicating that 5 and 6 were heterodimers of naphthalenones. Detailed analysis of the 1 H-1 H COSY and HMBC spectra (Figure 3) , compounds 5 and 6 had the same planar structures as two monomeric units leptothalenone A (1) and 10-norparvulenone (3) . The two monomeric units were connected through an ether bond (10-O-10') based on the HMBC correlations from H-10′ to C-7′ and C-10. Therefore, the planar structures of 5 and 6 were defined as 1,5-dihydroxy-3-methoxy-8-oxo-5,6,7,8-tetrahydronaphthalen-2-yl) The absolute configurations of 5 and 6 were established by comparing the experimental ECD data with the calculated values, in combination with biosynthetic considerations. Among the isolated monomeric naphthalenones, (+)-10-norparvulenone (3) was only obtained as an enantiomerically pure compound with S configuration, supporting by the X-ray single-crystal diffraction ( Figure S45 ). The biosynthetic pathway suggests that the configurations at C-4' of 5 and 6 were the same as those of the monomeric 10-norparvulenone (3) . The ECD of the remaining four configurations [(4R, 10S, 4′S) (4S, 10R, 4′S) (4R, 10R, 4′S) (4S, 10S, 4′S)] was calculated by a quantum chemical method at the [B3LYP/6 − 311 + g(2d,p)] level. The theoretical ECD curve of (4S, 10R, 4′S) carbon signals (two of which were carbonyls) that appeared pairwise in 13 C NMR spectrum indicating that 5 and 6 were heterodimers of naphthalenones. Detailed analysis of the 1 H-1 H COSY and HMBC spectra (Figure 3) , compounds 5 and 6 had the same planar structures as two monomeric units leptothalenone A (1) and 10-norparvulenone (3) . The two monomeric units were connected through an ether bond (10-O-10') based on the HMBC correlations from H-10′ to C-7′ and C-10.
Therefore, the planar structures of 5 and 6 were defined as 1,5-dihydroxy-3-methoxy-8-oxo-5,6,7,8-tetrahydronaphthalen-2-yl) The absolute configurations of 5 and 6 were established by comparing the experimental ECD data with the calculated values, in combination with biosynthetic considerations. Among the isolated monomeric naphthalenones, (+)-10-norparvulenone (3) was only obtained as an enantiomerically pure compound with S configuration, supporting by the X-ray single-crystal diffraction ( Figure S45 ). The biosynthetic pathway suggests that the configurations at C-4' of 5 and 6 were the same as those of the monomeric 10-norparvulenone (3). The ECD of the remaining four configurations [(4R, 10S, 4′S) (4S, 10R, 4′S) (4R, 10R, 4′S) (4S, 10S, 4′S)] was calculated by a quantum chemical method at the [B3LYP/6 − 311 + g(2d,p)] level. The theoretical ECD curve of (4S, 10R, 4′S) The absolute configurations of 5 and 6 were established by comparing the experimental ECD data with the calculated values, in combination with biosynthetic considerations. Among the isolated monomeric naphthalenones, (+)-10-norparvulenone (3) was only obtained as an enantiomerically pure compound with S configuration, supporting by the X-ray single-crystal diffraction ( Figure S45 ). The biosynthetic pathway suggests that the configurations at C-4' of 5 and 6 were the same as those of the monomeric 10-norparvulenone (3) . The ECD of the remaining four configurations [(4R, 10S, 4 S) (4S, 10R, 4 S) (4R, 10R, 4 S) (4S, 10S, 4 S)] was calculated by a quantum chemical method at the [B3LYP/6 − 311 + g(2d,p)] level. The theoretical ECD curve of (4S, 10R, 4 S) agreed well with the experimental ECD curve of (−)-5, and (4R, 10S, 4 S) was also in agreement with the experimental ECD curve of (+)-6 ( Figure 4) .
The known compound, (+)-10-norparvulenone (3) was identified by NMR, MS and optical rotation data analysis and comparison of spectroscopic data with the literature [9] . The optical rotation of 10-norparvulenone was [[α] which indicated their absolute configurations were opposite. The absolute configuration of 3 was 4S supported by X-ray single-crystal diffraction using anomalous scattering of Cu Kα radiation with Flack parameter = 0.00 (6) (Figure S45 ). Thus, compound 3 was named as (+)-10-norparvulenone.
All the compounds were tested for their inhibition activity against LPS-activated NO production in RAW264.7 cells using the Griess assay. Compound 6 displayed moderate inhibitory effects on the production of NO with an IC 50 value of 44.5 ± 1.1 µM, compared to the positive control indomethacin (IC 50 = 37.5 ± 1.6 µM), while the other compounds showed no significant anti-inflammatory activity (IC 50 > 100 µM). In addition, some of naphthalenones have been found to have cytotoxic activity according to previous studies [2, 5, 11, 12] . Thus, all the isolated compounds were evaluated for their cytotoxicity against A549 (lung cancer), HeLa (cervical cancer), and MCF-7 (breast cancer) human cancer cell lines using MTT assay and displayed no cytotoxicity against all three cell lines at 50 µM.
Materials and Methods

General Experimental Procedures
Optical rotations were measured on an MCP 200 polarimeter by using an Na lamp (Shimadzu). UV spectra were obtained on a Blue Star A spectrophotometer. A Fourier transformation infra-red spectrometer coupled with infra-red microscope EQUINOX 55 (Bruker, Rheinstetten, Germany) was used to record the IR spectra. NMR spectra were obtained on a Bruker Avance 400 MHz spectrometer with tetramethylsilane as the internal standard. HR-ESIMS data were obtained on a LTQ-Orbitrap LC-MS spectrometer (Thermo Corporation, Waltham, MA, USA). ESIMS spectra were obtained on an ACQUITY QDA (Waters Corporation, Milford, MA, USA). HPLC was carried out on an Essentia LC-16 with an SPD-16 Detector (Shimadzu, Shanghai, China). Column chromatography was carried out on silica gel (100-200 mesh, 200-300 mesh, Qing dao Marine Chemical Factory, Qingdao, China) and Sephadex LH-20 (GE Healthcare, Littile Chalfont, UK).
Fungal Material
The fungal strain 3608 was isolated from a crinoid collected in Xuwen, Zhanjiang City, Guangdong Province, China, in August 2014. It was identified as L. chartarum by ITS sequence, and the sequence data have been submitted to and deposited in the GenBank database under accession number MF980969. The fungal strain has been preserved at the school of marine science, Sun Yat-Sen University.
Extraction, Isolation, and Characterization
The fungus L. chartarum 3608 was cultured at room temperature (25-30 • C) for one month in 1000 mL Erlenmeyer flasks containing rice medium, composed of 60 mL rice, 80 mL H 2 O, and 3% sea salt. After 30 days of cultivation, the fermented rice substrate of 170 flasks was extracted three times with MeOH to yield the organic extract (70 g). The organic extract was portioned into three phases by successive extraction with n-hexane (43 g), CHCl 3 (8 g), EtOAc (17 g).
The CHCl 3 phase was subjected to a silica gel column (6 × 12 cm, 100-200 mesh) and was eluted with 80:20, 70:30, 60:40, 50:50, 40:60, 20 :80 and 0:100, 400 × 5 mL each gradient) to yield seven fractions (A-F). Fr. D was separated by silica gel CC (3.5 × 12 cm, 200-300 mesh), eluted with 60:40, 65:45, 50:50, 55:45 and 30:70) and combined with the same fractions based on the TLC results to yield Fr.D.1-Fr.D.5. Fr.D.1 was further subjected to silica gel CC (2 × 12 cm, 200-300 mesh) by isocratic elution by to yield compound 4 (6 mg). After recrystallization, the racemates of 1 and 2 were obtained from Fr.D.2 and Fr.D.3, respectively. The racemate of 1 was separated by chiral PR-HPLC (30% CH 3 CN-H 2 O, flow rate 1 mL/min, Ultimate Amy-SR column 10 × 250 mm, 5 µm) to yield (−)-1 (5 mg), (+)-1 (5 mg). The racemate of 2 was also separated by chiral PR-HPLC (30% CH 3 CN-H 2 O, flow rate 1 mL/min, Ultimate Amy-SR column 10 × 250 mm, 5 µm) to yield (−)-2 (7 mg), and (+)-2 (7 mg). Fr.E was subjected to silica gel CC (3.5 × 12 cm, 200-300 mesh) and eluted with PE-EtOAc (40:60) to yield 3 (300 mg). Fr.F was subjected to RP-C18 (3.5 × 12 cm), eluted with 60% MeOH-H 2 O, and then purified by PR-HPLC (60% MeOH-H 2 O, flow rate 1 mL/min, Ultimate XB-C18 column 10 × 250 mm, 5 µm) to yield 5 (3 mg) and 6 (2 mg), whose retention times were 52 min and 56 min, respectively. 3381, 2923, 1626, 1416, 1286, 1219, 1157, 1080 , 843 cm −1 ; 1 H NMR (400 MHz, MeOD) and 13 C NMR (100 MHz, MeOD) data, see Tables 1 and 2 3381, 2923, 1626, 1416, 1286, 1219, 1157, 1080 , 843 cm −1 ; 1 H NMR (400 MHz, MeOD) and 13 C NMR (100 MHz, MeOD) data, see Tables 1 and 2 
